Skip to main content

1 Result(s)

within Biomedicine Remove this filter Biomedicine, general Remove this filter Cancer Research Remove this filter Oncology Remove this filter Guy Van Camp Remove this filter Article Remove this filter

and

  1. Article

    Open Access

    Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

    The mTOR-inhibitor everolimus improves progression-free survival in advanced pancreatic neuroendocrine tumours (PNETs). However, adaptive resistance to mTOR inhibition is described.

    Timon Vandamme, Matthias Beyens, Ken Op de Beeck, Fadime Dogan… in British Journal of Cancer (2016)

    Download PDF (1897 KB) View Article